Qi-wen Tan

Dr. Qi-wen Tan


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LWLing Wang
Ling Wang
JXJin Xian
Jin Xian
MSMi Sun
Mi Sun
XWXue Wang
Xue Wang
XZXiaoming Zang
Xiaoming Zang
QTQi-wen Tan
Qi-wen Tan
Background: Patients with functional gastrointestinal disorders (FGIDs) also often have emotional symptoms, such as anxiety and depression. The main drugs used for the treatment of FGIDs mainly target single gastrointestinal symptoms and are not effective in regulating emotional symptoms. Evidence has shown that acupuncture can relieve gastrointestinal symptoms in FGIDs patients, but there is no high-quality evidence to show that acupuncture can relieve psychological symptoms in these patients.Objectives: To systematically evaluate the clinical efficacy and safety of acupuncture for emotional symptoms in patients with FGIDs.Methods: Randomized controlled trials (RCTs) published from database inception through July 31, 2021, were retrieved from three English-language databases (PubMed, the Cochrane Central Register of Controlled Trials, and Embase) and five Chinese-language databases (the China National Knowledge Infrastructure, Wanfang, VIP, Chinese Biomedical, and TCM Literature Analysis and Retrieval databases). RCTs that compared acupuncture with sham acupuncture and pharmacotherapy were included in this study. The score on the depression or anxiety scale after treatment were considered as primary outcomes. The ‘meta’ package (version 4.19–0) in RStudio 1.1.463 was used to analyse the data.Results: A total of 2151 patients from 24 RCTs were included in this study. Compared with sham acupuncture, acupuncture was not significantly better at relieving anxiety (standardized mean difference [SMD] -0.35, 95% CI −1.05 to 0.33) and depression (SMD -0.32, 95% CI −0.71 to 0.07) symptoms. Compared with pharmacotherapy, acupuncture was significantly better at relieving anxiety (SMD -0.64, 95% CI -0.93 to -0.35) and depression (SMD -0.46, 95% CI -0.69 to -0.22) symptoms.Conclusions: This meta-analysis found that acupuncture can alleviate emotional symptoms in FGID patients better than pharmacotherapy. However, it is not clear whether this effect is based on the placebo effect, specific effect or nonspecific effect of acupuncture. The evidence should be proven by rigorously designed RCTs in the future.PROSPERO registration number: CRD42021271899.

17 May 2022 in Acupuncture in Medicine
Verified
Journal Article
Closed access
JXJin Xian
Jin Xian
LWLing Wang
Ling Wang
CZChangyun Zhang
Changyun Zhang
JWJian Wang
Jian Wang
YZYushuo Zhu
Yushuo Zhu
QTQi-wen Tan
Qi-wen Tan
Background: Sepsis is a life-threatening organ dysfunction caused by dysregulation of the host response to infection. Acupuncture is used for treatment of inflammatory diseases; however, its effectiveness and safety as a complementary therapy for sepsis has not been fully explored. Methods: Data were retrieved from eight databases. Randomized controlled trials (RCTs) that compared acupuncture plus conventional therapies versus conventional therapies alone were included. Pre-specified primary outcomes were mortality at 28 days and Acute Physiologic and Chronic Health Evaluation (APACHE) II scores. Results: A total of 17 studies with 1099 participants were included in this study. In terms of the primary outcomes, acupuncture plus routine therapy reduced mortality at 28 days (risk ratio (RR)): 0.69, 95% confidence interval (CI): 0.52 to 0.91, p < 0.001) and APACHE II scores (mean difference (MD): −2.84, 95% CI: −4.09 to −1.58, p < 0.001) at day 7 after treatment compared with routine therapy alone. In terms of secondary outcomes, acupuncture plus routine therapy reduced white blood cell counts and levels of procalcitonin (PCT), tumor necrosis factor (TNF)-α, interleukin (IL)-6 and lactic acid and intra-abdominal pressure (IAP), and improved CD3+, CD4+ and monocytes of human leukocyte antigen (HLA)-DR at day 7 after treatment compared with routine therapy alone. However, acupuncture plus routine therapy had no significant effects on levels of IL-10, C-reactive protein (CRP), CD8+ and CD4+/CD8+ ratios compared with routine therapy alone. Quality of evidence was low to very low for all parameters (GRADE). Conclusion: The available evidence showed that combination of acupuncture and routine therapy may have benefit for sepsis compared with use of routine therapy only. Due to the low degree of certainty regarding its effects, further research is required. Trial registration number: ICRD42019141491 (PROSPERO).

27 January 2022 in Frontiers in Psychiatry
Verified
Journal Article
Open access
JXJin Xian
Jin Xian
LWLing Wang
Ling Wang
MSMi Sun
Mi Sun
XWXue Wang
Xue Wang
XZXiao-Ming Zang
Xiao-Ming Zang
QTQi-wen Tan
Qi-wen Tan
Background: Subthreshold depression refers to a state of mental sub-health that has depressive symptoms but does not meet the diagnostic criteria for major depressive disorder. It is a strong risk factor for depression and is related to an increase in suicide and mortality. Studies suggest that acupuncture may be effective in the treatment of subthreshold depression, but no evidence has proven that the efficacy of acupuncture for subthreshold depression is a specific therapeutic effect or a placebo effect.Methods: This will be a prospective, randomized, controlled, and double-blind study of 64 patients with subthreshold depression. They will be randomly assigned as verum or minimal acupuncture group members. Patients in the verum acupuncture group will receive acupuncture at the acupoints, and those in the minimal acupuncture group will receive minimal acupuncture at non-acupoints. The interventions will be delivered over an 8-week period. The primary outcome measure will be the Hamilton Depression Scale-17 (HAMD-17). The secondary outcome measures will be the 9-item Patient Health Questionnaire (PHQ-9), 7-item Generalized Anxiety Disorder (GAD-7), and SF-12v2 Health Survey. The assessments will occur at baseline, 4 weeks, 8 weeks, and during a follow-up period.Discussion: The protocol uses a randomized controlled trial to examine the effectiveness of acupuncture for subthreshold depression and to further study the mechanisms of its effect.

1 January 2020 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
NXNing Xiao
Ning Xiao
YLYang Li
Yang Li
MSMing-Lu Shao
Ming-Lu Shao
HCHua-Feng Cui
Hua-Feng Cui
CZChang-Yun Zhang
Chang-Yun Zhang
QTQi-wen Tan
Qi-wen Tan
Background. Acupuncture preconditioning was able to reduce the extent of ischaemia reperfusion (I/R) injury. Previous studies have shown that electroacupuncture (EA) pretreatment at T4‐T5 Jiaji (EX‐B2) acupoints had cardioprotective effects against myocardial I/R injury. However, the molecular mechanism remains inconclusive. Methods. Wistar rats were pretreated with electroacupuncture for 7 days at the Neiguan (PC6), T4‐T5 Jiaji (EX‐B2), Yanglingquan (GB34), and Quchi (LI11) acupoints, which belong to different meridians. Then, we investigated the genome‐wide gene expression profiles of rats prestimulated at these acupoints after I/R injury. Results. Our study revealed previously unknown cardioprotective roles of T4‐T5 Jiaji (EX‐B2) acupoints in the I/R progression. The extent of myocardial injury was significantly decreased in the Jiaji group compared with the I/R group. In addition, our data are among the first to link the EA preconditioning at Neiguan (PC6) acupoints and circadian rhythm in the I/R model. Also, for the first time, we explored the meridian and acupoint specificity involved in EA pretreatment at the heart meridian, in which Yanglingquan and Quchi acupoints were selected as the control group for heart‐divergent‐meridian and nonheart‐meridian acupoints. Conclusions. The present study suggested that EA pretreatment at Jiaji alters genome‐wide gene expression and protects the rat myocardium against I/R injury, which are most likely through neurohumoral regulation.

20 February 2026 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
JXJin Xian
Jin Xian
LWLing Wang
Ling Wang
RSRuPing Shang
RuPing Shang
MSMi Sun
Mi Sun
HYHui-Juan Yua
Hui-Juan Yua
QTQi-wen Tan
Qi-wen Tan
Background: Subthreshold depression (SD) is an intermediate state between normal mood and major depressive disorder (MDD), but its biological underpinnings remain insufficiently understood. Increasing evidence suggests that gut microbiota and host metabolic alterations may contribute to early depressive pathophysiology. Methods: We performed full-length 16S rRNA gene sequencing and LC–MS-based untargeted metabolomics on stool and plasma samples obtained from SD subjects and healthy controls. Microbial diversity, taxonomic composition, metabolic pathway alterations, and gut microbiota–metabolite associations were analyzed using bioinformatics pipelines, KEGG annotation, and Spearman correlation analysis. Results: SD patients exhibited marked gut microbial disturbances, including reduced microbial diversity and altered abundances of key genera such as decreased Eubacterium hallii group, Blautia, Dorea, and Agathobacter, and increased Escherichia–Shigella, Monoglobus, and Lachnoclostridium. Metabolomic profiling identified widespread metabolic perturbations, mainly affecting lipid metabolism, steroid hormone biosynthesis, and amino acid pathways. Exploratory correlation analysis indicated that beneficial taxa (e.g., Eubacterium hallii group and Blautia) were positively associated with specific glycerophospholipid and steroid hormone metabolites, whereas inverse associations were observed for other lipid-related metabolites. Conclusion: This integrative microbiome–metabolome analysis demonstrates that SD is accompanied by early disruptions in gut microbial composition and systemic metabolism, particularly within lipid-related pathways. These findings suggest that gut microbiota dysbiosis may reflect early metabolic dysregulation and depression-related biological vulnerability in SD and highlight the gut microbiota as a candidate biological target for early identification and intervention.

23 December 2025 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
JXJin Xian
Jin Xian
LWLing Wang
Ling Wang
MSMi Sun
Mi Sun
XZXiao-Ming Zang
Xiao-Ming Zang
HYHui-Juan Yu
Hui-Juan Yu
QTQi-wen Tan
Qi-wen Tan
Background Subthreshold depression (SD), characterized by depressive symptoms not meeting major depressive disorder (MDD) criteria, poses a significant risk for MDD development. Acupuncture has shown promise for SD, though its efficacy beyond placebo remains unclear. Therefore, we designed this study to evaluate the efficacy of verum acupuncture (VA) compared to sham acupuncture (SA) for SD. Methods A randomized clinical trial was conducted at the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, China, from September 2021 to October 2023. Participants with SD were randomized 1:1 to receive either VA or SA for 8 weeks, with 12-week follow-up. The primary outcome was the change in Hamilton Depression Scale-17 (HAMD-17) scores from baseline to 8 weeks. Results Of 231 screened patients, 64 participants (71.87% female; mean age, 29.83 [SD 6.84] years) were included. Fifty-nine participants (92.2%) completed the study. The mean reduction in HAMD-17 scores from baseline to week 8 was-7.28 (95% CI,-8.26 to-6.3) in the VA group and-3.80 (95% CI,-4.42 to-2.77) in the SA group. The between-group difference at week 8 was-4.08 (95% CI,-5.15 to-3.02; P < .001). Effects persisted during the 12-week follow-up. No serious adverse events occurred. Conclusions Acupuncture demonstrated significant therapeutic effects for SD compared to SA, with benefits extending beyond placebo. These findings support acupuncture as a specific and effective intervention for SD. However, the study's limitations, including its single-center design and relatively young sample, should be considered when generalizing the results.